2-ethyl-6-methyl-3,4-dihydro-2H-1,4-benzoxazine
- $252 - $1443.75
- Product name: 2-ethyl-6-methyl-3,4-dihydro-2H-1,4-benzoxazine
- CAS: 898808-64-5
- MF: C11H15NO
- MW: 177.24
- EINECS:
- MDL Number:MFCD11603426
- Synonyms:2-ethyl-6-methyl-3,4-dihydro-2H-1,4-benzoxazine;2H-1,4-Benzoxazine, 2-ethyl-3,4-dihydro-6-methyl-
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500mg
- 0.5G
- 1G
- 5G
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0083967
- Product description2-ETHYL-6-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZINE 95.00%
- Packaging0.5G
- Price$726
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0083967
- Product description2-ETHYL-6-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZINE 95.00%
- Packaging1G
- Price$808.5
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0083967
- Product description2-ETHYL-6-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZINE 95.00%
- Packaging5G
- Price$1443.75
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number038448
- Product description2-Ethyl-6-methyl-3,4-dihydro-2H-1,4-benzoxazine
- Packaging500mg
- Price$252
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0083967 | 2-ETHYL-6-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZINE 95.00% | 0.5G | $726 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0083967 | 2-ETHYL-6-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZINE 95.00% | 1G | $808.5 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0083967 | 2-ETHYL-6-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZINE 95.00% | 5G | $1443.75 | 2021-12-16 | Buy |
Matrix Scientific | 038448 | 2-Ethyl-6-methyl-3,4-dihydro-2H-1,4-benzoxazine | 500mg | $252 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|